Remepy
Nira Saporta (Rivner) is a clinical psychologist with extensive experience in various clinical settings and roles. Nira is currently the Co-founder and Chief Therapeutics Officer at Remepy. Throughout their career, Nira has also worked at Sheba Tel HaShomer City of Health, University of Haifa, and various other organizations in psychology and product marketing. Nira holds a PhD in Psychology from the University of Haifa, with previous degrees in Clinical Child Psychology and Biology and Psychology.
Previous companies
This person is not in any offices
Remepy
Remepy is Pioneering Hybrid Drugs™. We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.